Gene Activity Profiles in Adults With Spinal Tuberculosis
Compares blood gene activity in adults with spinal tuberculosis, with or without spread.
Key facts
- Who runs it
- University of Cape Town
- Where
- Cape Town, South AfricaSee the site
- Trial code
- Registry title
- Gene Expression Profiles in Spinal Tuberculosis.
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 25 Oct 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Record updated
- 23 August 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with tuberculosis of the spine (TB spine). It compares gene activity in people whose TB stays in the spine with people whose TB has spread to other organs.
- Age
- 18 years or older, and a body weight of at least 40 kg (88 lb).
- Sex
- All sexes can join.
- Disease stage
- TB of the spine, based on clinical and radiological criteria.
Main reasons for not taking part
- Pregnancy, or wanting to become pregnant within the next 6 months
- Uncontrolled diabetes
- Alcohol or substance abuse that might interfere with taking medication during the trial
- Positive SARS-CoV-2 PCR test in the past 4 weeks
- Known or suspected cancer on MRI, or suspected inflammatory or rheumatological disease
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Participant has completed the written informed consent process prior to undergoing any clinical evaluations and willing to undergo HIV testing
- TB spine based on clinical and radiological criteria
- Age 18 or older with a body weight of at least 40 kg body weight
- Able and willing to return to follow-up
- Willing to have samples, including DNA including RNA extraction, stored
- Willing to consistently practice a highly reliable method of pregnancy prevention
Who cannot take part
- Alcohol and substance abuse which might interfere with medication adherence during the trial
- Suspicion of malignancy on MRI or known malignancy
- Suspicion of inflammatory disease and other rheumatological conditions
- Uncontrolled diabetes (HbA1c ≥ 6.5% / random glucose concentration ≥11.1 mmol/l, fasting plasma glucose ≥ 7.0 mmol/l)
- Pregnancy or active desire to become pregnant within the next 6 months
- Positive SARS-CoV-2 PCR in the past 4 weeks
- Any person for whom the physician feels this study is not appropriate
This trial is currently available in South Africa.
- Groote Schuur HospitalCape Town, South AfricaContact: Julian F Scherer, MDTaking people
About the trial
What the trial wants to find out
Tuberculosis (TB) is one of the top ten causes of death worldwide with approximately 10 million cases globally and 1.2 million deaths. Sub-Saharan Africa carries the highest burden of TB. South Africa has one of the highest HIV and TB rates worldwide with an HIV prevalence rate in adults of 19% and a TB case notification rate of 615/100,000 in 2019. Over many years, focus has been paid to pulmonary TB and extrapulmonary TB (EPTB) has received only little attention even though it accounts for almost a quatre of all TB cases. The diagnosis of EPTB remains challenging simply because sample collection requires invasive procedures in the absence of a blood-based diagnostic test. Spinal TB (spondylitis or spondylodiscitis caused by Mycobacterium tuberculosis) - often known as Pott's disease - accounts for up to 10% of EPTB and affects young children, people with HIV-coinfection and elderly, and often leads to lifelong debilitating disease due to devastating deformation of the spine and compression of neural structures. Little is known with regards to the extent of disease and isolated TB spine as well as a disseminated form of TB spine have been described. The latter presents with a spinal manifestation plus disseminations to other organs such as the lungs, pleura, lymph nodes, the GIT or urinary tract or even the brain.
Read full original descriptionShow less
In the Spinal TB X cohort, the investigators aim to describe the clinical phenotype of spinal TB using whole body PET/CT and identify a specific gene expression profile for the different stages of dissemination and compare findings to previously described signatures for latent and active pulmonary TB. A blood-based test for spinal TB would lead to earlier diagnosis and treatment in all settings globally and improve treatment outcome of this devastating disease.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing Gene Expression Profiles of Adults With Isolated Spinal TB to Disseminated Spinal TB Identified by 18FDG-PET/CT at Time of Diagnosis, 6-and 12-months Follow-up
- Plain-language title
- Gene Activity Profiles in Adults With Spinal TuberculosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Comparing gene expression profiles of adults with isolated spinal tuberculosis to disseminated spinal tuberculosis identified by 18FDG-PET/CT at time of diagnosis, 6- and 12-months follow-up: classifying clinical stages of spinal tuberculosis and monitoring treatment response (Spinal TB X cohort study).Journal of orthopaedic surgery and research, 2024
- Record updated
- 23 August 2024